Leading the Way in Life Science Technologies

GEN Exclusives

More »

New Products

Whether you are searching for a DNA purification kit or outfitting a cGMP facility, GEN’s comprehensive new product database is your first and only stop. Conveniently categorized and searchable, the database covers the latest innovations from industry-leading suppliers.

Algorithm for Sequence-Analysis Software

SoftGenetics

The NextGENe paired-read Mapper is an enhanced alignment algorithm that helps reduce the false-positive rate of short-read paired-end and mate-pair sequences from next-generation sequencing platforms. This algorithm pairs the reads prior to mapping in order to increase sequence uniqueness. The pa...

Chimerism Software

SoftGenetics

This new automated chimerism software, ChimerMarker™, integrates analysis operations for initial donor/recipient compatibility and post engraftment longitudinal studies. The new software is compatible with outputs from major capillary electrophoresis platforms as well as commercially availa...

Genotyping Processor

SoftGenetics

GeneMarker MTP processes up to six varying chemistries or size standards in a single analysis run. Following the genotyping of the six projects, users have access to the applications found in GeneMarker software including MLPA®, MS-MLPA, Trisomy, Fragile X, AFLP, MSI, LOH, SNaPshot®, and ...

Sequence-Data Analysis Tool

SoftGenetics

The newest version of NextGENe software for the analysis of sequencing-platform data is now available. NextGENe v 2.0 incorporates several new viewing and filtering capabilities including a new variant confidence scoring tool, which scores each found variant by four different factors, providing a...

Sequencing Analysis Software

SoftGenetics

Mutation Surveyor software is for variant analysis of Sanger sequencing data. The latest version features a QC report with color-coded confidence scoring of all found variant calls. It groups replicated positions into a report cell, and mutation calls are shown where a variant has been identified...